EvolutionaryScale releases ESM3 model for protein design, backed by Lux Capital and NVIDIA.

From NVIDIA: 2024-06-25 06:00:25

EvolutionaryScale has released the ESM3 model for protein design, with backing from Lux Capital and NVIDIA. The model uses 98 billion parameters and vast amounts of data, offering new possibilities in drug development and research. The AI technology is set to accelerate protein discovery and revolutionize in silico biological research.

ESM3 is a breakthrough in generative AI, assisting biologists and protein designers in creating new proteins and improving their understanding of protein engineering. The model is capable of solving complex protein design problems and will soon be available for non-commercial use and integration with NVIDIA BioNeMo for drug discovery applications.



Read more at NVIDIA: EvolutionaryScale Debuts With ESM3 Generative AI Model for Protein Design